CD40L has been shown to promote atherosclerosis and plaque instability,25 to retain inflammatory effects through promotion of platelet-monocyte aggregates and production of reactive oxygen species.26 In addition to inflammatory properties, platelet CD40L stabilizes platelet-platelet aggregates, target of numerous antiplatelet agents used in the treatment of ACS.27 This evidence concerns the gene CD40LG and atherosclerosis.